Sangamo BioSciences to Webcast Presentations at Investor and Analys...( RICHMOND Calif. Dec. 4 /- Sangamo...)
Navigation Links
| HOME >> BIOLOGY >> TECHNOLOGY |
Sangamo BioSciences to Webcast Presentations at Investor and Analyst Briefing
Date:12/4/2007
RICHMOND, Calif., Dec. 4 /PRNewswire-FirstCall/ -- Sangamo BioSciences, Inc. (Nasdaq: SGMO) announced today that the company will update the financial community on its latest developments in several of its therapeutic programs and discuss other business matters at its annual Investor and Analyst Briefing that will be held from 4:30 to 6:30 pm ET, on Wednesday, December 5, 2007.
The presentation will be webcast live and may be accessed via a link on the Sangamo BioSciences website in the Investor Relations section http://investor.sangamo.com/index.cfm under Events and Presentations. The presentation will be archived on the Sangamo website for two weeks after the event.
About Sangamo
Sangamo BioSciences, Inc. is focused on the research and development of
novel DNA-binding proteins for therapeutic gene regulation and
modification. The most advanced ZFP Therapeutic(TM) development program is
currently in Phase 2 clinical trials for evaluation of safety and clinical
effect in patients with diabetic neuropathy. Phase 1 clinical trials are
ongoing to evaluate a ZFP Therapeutic for peripheral artery disease. Other
therapeutic development programs are focused on cancer and HIV/AIDS,
neuropathic pain, nerve regeneration, Parkinson's disease and monogenic
diseases. Sangamo's core competencies enable the engineering of a class of
DNA-binding proteins known as zinc finger DNA-binding proteins (ZFPs). By
engineering ZFPs that recognize a specific DNA sequence Sangamo has created
ZFP transcription factors (ZFP TF(TM)) that can control gene expression
and, consequently, cell function. Sangamo is also developing
sequence-specific ZFP Nucleases (ZFN(
'/>"/>
| SOURCE Sangamo BioSciences, Inc. Copyright©2007 PR Newswire. All rights reserved |
Related biology technology :
1. Sangamo BioSciences Presents Data Demonstrating In Vivo Protection Against HIV Infection by CCR5-ZFN Therapeutic
2. Sangamo BioSciences to Present at the UBS Global Life Sciences Conference
3. Sangamo BioSciences to Present at the 2007 BIO InvestorForum
4. Sangamo BioSciences Announces Third Quarter 2007 Conference Call and Webcast
5. Sangamo BioSciences Announces ZFP Therapeutic Data From Nerve Regeneration Program at Society for Neuroscience Meeting
6. Sangamo BioSciences to Present at the Piper Jaffray Health Care Conference
7. Sangamo BioSciences to Present at the BMO Capital Markets Health Care Conference
8. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
9. Selection of Development Candidate Triggers $0.5 Million Milestone Payment to Ardea Biosciences, Inc.
10. ImmuneRegen BioSciences Files 8-K that Highlights Enclosed Shareholder Letter Discussing Recent Achievements and Outlook
11. ONCOSCIENCE AG, THE EUROPEAN PARTNER OF YM BIOSCIENCES, ANNOUNCES COMPLETION OF PATIENT ENROLLMENT IN PHASE III BRAIN CANCER TRIAL OF NIMOTUZUMAB
Post Your Comments:
(Date:11/25/2009)...ire/--ResearchTrianglePark-basedCnanozInc.unveiled...ficationsystemNanoPure(TM)developedfromcarbonnanot....MinisterViswarupandotherleadersinHyderabad,Indiat...nology(IIT)Kanpur,confirmedthatthemajorityofthedri...xtremelyhazardoustohumanhealth. ,, Thetechnolog...
(Date:11/25/2009)...-BiotechfirmReplikinsLtd.,whichhasanalyzedtheH1N1v...ction,outbreak,andprogressofthecurrentH1N1pandemic....ThenewdatashowsthatthelethalityoftheH1N1("SwineFl...hevirus,scurrentoutbreakinthespringof2009toresting...rus,infectivitycount,however,remainsincreased. ,...
(Date:11/25/2009)...or to Speak at Economic Club of Canada , ...5, 2009 -- Ambassador to Speak at Economic Club of...ador for International Investment, and Chairman an...ography of David Appia go to www.investinfrance.o... meet with press to discuss recent pro-business in...
(Date:11/25/2009)...v.25/PRNewswire/--Formanybusinesses,2009hasbeenapa...dfastestgrowingnetworkofexpertphysiciansspecializi...mones has grownthenumberof physiciansinitsnetwor...nprogresstoaddmorephysician-ownedcenters,including...tyear ,BodyLogicMDhasopened13newbioidenticalhormon...
Breaking Biology Technology:North Carolina-based Cnanoz Unveils NanoPure(TM) to Government Leaders in Hyderabad, India 2Biological H1N1 Vaccines: Too Little, Too Late 2Biological H1N1 Vaccines: Too Little, Too Late 3Biological H1N1 Vaccines: Too Little, Too Late 4French Ambassador for International Investment to Visit Toronto December 11 2Nation's Largest Network of Doctors Specializing in Bioidentical Hormones Grows at an Exponential Rate 2Nation's Largest Network of Doctors Specializing in Bioidentical Hormones Grows at an Exponential Rate 3[0] North Carolina-based Cnanoz Unveils NanoPure(TM) to Government Leaders in Hyderabad, India[0] Biological H1N1 Vaccines: Too Little, Too Late[0] French Ambassador for International Investment to Visit Toronto December 11[0] Nation's Largest Network of Doctors Specializing in Bioidentical Hormones Grows at an Exponential Rate
... Inc. (Nasdaq: BMRN ) today announced that Joshu...Development of BioMarin, will present a company up...go on Thursday, May 14, 2009 at 10:40 a.m. CT. ,...cast of the conference call via the investor secti...eplay of the call will be archived on the site for...
..., Inc.,(Nasdaq: DCGN ) today announced that it wi... in a press release to be issued on Monday, May 11...ompany will host a live webcast of,its conference ... highlights,on Tuesday, May 12, at 8am Eastern Day... The webcast can be accessed through the Investor...
...CVD ) announced that it has elected John McCartney...rrently serves as chairman of the board of A.M. Ca..., services, and supply chain solutions. He was fo...S. Robotics (USR), a multibillion dollar provider ...r executive in the management team that grew USR f...
Other Biology Technology:BioMarin to Present at the Baird Growth Stock Conference 2deCODE genetics Announces Webcast of Conference Call to Discuss First Quarter 2009 Financial Results 2Covance Elects John McCartney to Company's Board of Directors 2(Date:11/26/2009)...hicillin-resistant Staphylococcus Aureus ) and ot...n as low-temperature plasma prototype devices have...ailing bactericidal cocktails. , Two prototype d...nfection of healthy skin (e.g. hands and feet) in ...e a lethal threat; and another to shoot bacteria-k...
(Date:11/25/2009)... Calif.Scientists at the California Institute of T...rimitive emotion-like behavior in the fruit fly, ...h may be relevant to the relationship between the ...peractivity disorder (ADHD), are described in the ...rosophila brain contains only about 20,000 neuron...
(Date:11/25/2009)...a hormone produced in the stomach, may be used to ...arkinson,s disease, Yale School of Medicine resear...e of the Journal of Neuroscience . , Parkinson,...neurons in an area of the midbrain known as the su...production. Reduced production of dopamine in lat...
Breaking Biology News(10 mins):Plasma produces KO cocktail for MRSA 2Plasma produces KO cocktail for MRSA 3Caltech scientists find emotion-like behaviors, regulated by dopamine, in fruit flies 2Caltech scientists find emotion-like behaviors, regulated by dopamine, in fruit flies 3Caltech scientists find emotion-like behaviors, regulated by dopamine, in fruit flies 4Hormone ghrelin can boost resistance to Parkinson's disease 2JNCI news brief 3A Hepatitis B virus mutations may predict risk of liver cancer 50680 1American Scientific Resources Announces Acting CFO Transition to Full Time 50677 1American Scientific Resources Announces Acting CFO Transition to Full Time 50677 2Nu Skin Enterprises to Announce Second Quarter 2009 Results 50675 1...gning something, its hard to find a better source ...nciple, a diverse, interdisciplinary group of rese...oratory is mimicking bacteria to synthesize magnet...ting and delivery, in magnetic inks and high-dens.... , Commercial room-temperature synthesis of ferr...
...e debate is familiar to most people, and modern co...o. A new paper published this week in the open-acc...ilar balance between the genes we inherit—nature—a...s of traits in yeast. As we approach the age of pe...ng about the genetic variations we carry, it is im...
...riations ensure that no two people are exactly ali...e tools and the knowledge to predict how individua...recise and effective treatment. At the 2008 Annual...search, April 12 16, researchers present data on ...nown treatments for breast cancer, pediatric neuro...
Other Biology News:Researchers mimic bacteria to produce magnetic nanoparticles 2Researchers mimic bacteria to produce magnetic nanoparticles 3Biomarkers allow doctors to match therapy to patient 2Biomarkers allow doctors to match therapy to patient 3Biomarkers allow doctors to match therapy to patient 4Biomarkers allow doctors to match therapy to patient 5Biomarkers allow doctors to match therapy to patient 6Biomarkers allow doctors to match therapy to patient 7Cover Glasses from Santa Cruz Biotechnology, Inc.
G-Protein Coupled Receptor Assay from GE Healthcare, formerly Amersham Biosciences
Amino acid mixture excluding l-[U-14C]methionine from GE Healthcare, formerly Amersham Biosciences
Spheroplast Kit for Yeast from Invitrogen
Biology Products:| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |